QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Backlund, M. Articles by Ingelman-Sundberg, M. Search for Related Content PubMed PubMed Citation Articles by Backlund, M. Articles by Ingelman-Sundberg, M.

Different Structural Requirements of the Ligand Binding Domain of the Aryl Hydrocarbon Receptor for High- and Low-Affinity Ligand Binding and Receptor Activation

Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

The aryl hydrocarbon receptor (AhR) functions as a ligand-activated transcription factor that is responsible for the regulation of several response genes, of which the best characterized is the CYP1A1 gene. The present study was undertaken to elucidate the mechanism of activation of the AhR by omeprazole (OME), 2-mercapto-5-methoxybenzimidazole (MMB), and primaquine (PRQ), compounds that have previously been reported to induce CYP1A1 expression but that are not typical AhR ligands. All compounds caused a significant increase in luciferase activity in rat H4IIE and human HepG2 hepatoma cells transfected with a Gal4-AhR construct and the corresponding Gal4-Luc reporter gene. Furthermore, MMB and PRQ, but not OME, were capable of transforming cytosolic AhR to a DNA-binding form and displacing AhR-bound [³H]TCDD in rat hepatic cytosol in vitro. By performing site-directed mutagenesis of residues in the ligand-binding domain of the Gal4-AhR, a construct containing a Y320F substitution was found to be resistant to activation by OME, MMB, and PRQ, but not by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Comparable affinities of [³H]TCDD-binding to the wild-type and the Y320F mutant Gal4-proteins, expressed in human embryonic kidney 293 cells, were obtained in the ligand-binding assay. In contrast, the competition of receptor-bound [³H]TCDD by PRQ was absent from Gal4-Y320F but not from Gal4-AhR cell extracts. The results of this study confirm that MMB and PRQ are low-affinity ligands for the AhR and suggest that high- and low-affinity ligands interact with different residues of the AhR ligand-binding pocket. In addition, the data presented here indicate that Tyr³²⁰ plays an important role in AhR activation.

Received June 26, 2003; accepted November 7, 2003.

Address correspondence to: Maria Backlund, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden. E-mail: maria.backlund{at}imm.ki.se

This article has been cited by other articles:

				C. A. Flaveny, I. A. Murray, C. R. Chiaro, and G. H. Perdew Ligand Selectivity and Gene Regulation by the Human Aryl Hydrocarbon Receptor in Transgenic Mice Mol. Pharmacol., June 1, 2009; 75(6): 1412 - 1420. [Abstract] [Full Text] [PDF]

				P. Monteiro, D. Gilot, S. Langouet, and O. Fardel Activation of the Aryl Hydrocarbon Receptor by the Calcium/Calmodulin-Dependent Protein Kinase Kinase Inhibitor 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid (STO-609) Drug Metab. Dispos., December 1, 2008; 36(12): 2556 - 2563. [Abstract] [Full Text] [PDF]

				J. E. Bohonowych and M. S. Denison Persistent Binding of Ligands to the Aryl Hydrocarbon Receptor Toxicol. Sci., July 1, 2007; 98(1): 99 - 109. [Abstract] [Full Text] [PDF]

				G. R. Anderson, A. Hasan, H. Yin, I. Qadri, and L. C. Quattrochi Regulation of the CYP1A1 Gene by 2,3,7,8-Tetrachlorodibenzo-p-dioxin but Not by beta-Naphthoflavone or 3-Methylcholanthrene Is Altered in Hepatitis C Virus Replicon-Expressing Cells Mol. Pharmacol., September 1, 2006; 70(3): 1062 - 1070. [Abstract] [Full Text] [PDF]

				K. J. Coe, S. D. Nelson, R. G. Ulrich, Y. He, X. Dai, O. Cheng, M. Caguyong, C. J. Roberts, and J. G. Slatter PROFILING THE HEPATIC EFFECTS OF FLUTAMIDE IN RATS: A MICROARRAY COMPARISON WITH CLASSICAL ARYL HYDROCARBON RECEPTOR LIGANDS AND ATYPICAL CYP1A INDUCERS Drug Metab. Dispos., July 1, 2006; 34(7): 1266 - 1275. [Abstract] [Full Text] [PDF]

				A. K. Peters, S. Nijmeijer, K. Gradin, M. Backlund, A. Bergman, L. Poellinger, M. S. Denison, and M. Van den Berg Interactions of Polybrominated Diphenyl Ethers with the Aryl Hydrocarbon Receptor Pathway Toxicol. Sci., July 1, 2006; 92(1): 133 - 142. [Abstract] [Full Text] [PDF]

				S. I. Karchner, D. G. Franks, S. W. Kennedy, and M. E. Hahn The molecular basis for differential dioxin sensitivity in birds: Role of the aryl hydrocarbon receptor PNAS, April 18, 2006; 103(16): 6252 - 6257. [Abstract] [Full Text] [PDF]

				S. Koyano, Y. Saito, H. Fukushima-Uesaka, S. Ishida, S. Ozawa, N. Kamatani, H. Minami, A. Ohtsu, T. Hamaguchi, K. Shirao, et al. FUNCTIONAL ANALYSIS OF SIX HUMAN ARYL HYDROCARBON RECEPTOR VARIANTS IN A JAPANESE POPULATION Drug Metab. Dispos., August 1, 2005; 33(8): 1254 - 1260. [Abstract] [Full Text] [PDF]

				S. Chen, T. Operana, J. Bonzo, N. Nguyen, and R. H. Tukey ERK Kinase Inhibition Stabilizes the Aryl Hydrocarbon Receptor: IMPLICATIONS FOR TRANSCRIPTIONAL ACTIVATION AND PROTEIN DEGRADATION J. Biol. Chem., February 11, 2005; 280(6): 4350 - 4359. [Abstract] [Full Text] [PDF]